论文部分内容阅读
通过实地调研与网络调研相结合,运用Logistic回归分析方法,分析影响医药企业技术创新意愿的内外部环境因素,为制定激发医药企业技术创新内在动力的相关政策提供实证依据。结果表明,企业自身技术创新的能力和研发部门人员投入是影响企业技术创新意愿的主要内部因素;专利保护制度和市场进入壁垒是影响企业技术创新意愿的最主要外部因素。因此,企业应合理配置资源投入,提高自身技术创新能力。政府应该完善专利保护政策,保护企业研发成果;营造良好的市场环境,完善新药市场准入制度。
Through the combination of field investigation and network research, the paper uses Logistic regression analysis method to analyze the internal and external environmental factors that affect the willingness of technological innovation of pharmaceutical enterprises and provide empirical evidence for the formulation of relevant policies to stimulate the internal motivation of pharmaceutical enterprises. The results show that the enterprise’s own technological innovation ability and R & D personnel input are the main internal factors that affect the enterprise’s technological innovation intention. The patent protection system and market entry barrier are the most important external factors that affect the enterprise’s technological innovation intention. Therefore, enterprises should rationally allocate resources to improve their own technological innovation capability. The government should improve the patent protection policy to protect the R & D results; create a good market environment and improve the market access system for new drugs.